ロード中...
Frequency of Bioprosthetic Valve Fracturing Utilization in an All-Comers Valve-in-Valve TAVR Cohort
Introduction: Valve-in-valve TAVR (ViV-TAVR) is an established treatment for failing surgical aortic valves in patient at high surgical risk. Elevated transprosthetic gradients are common after ViV-TAVR. Previously, bench tests showed feasibility of bioprosthetic valve fracturing (VF) using high-pre...
保存先:
| 出版年: | Front Cardiovasc Med |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8280286/ https://ncbi.nlm.nih.gov/pubmed/34277723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2021.653871 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|